[HTML][HTML] Identification of N7-methylguanosine-related lncRNAs for the risk stratification of hepatocellular carcinoma
Y Li, K Zhao, R Wu, J Wang, Q Wang… - Journal of …, 2023 - ncbi.nlm.nih.gov
Background Hepatocellular carcinoma (HCC) is one of the most common malignancies in
the world. The N7-methylguanosine (m7G) modification is related to the biological …
the world. The N7-methylguanosine (m7G) modification is related to the biological …
A novel defined N7-methylguanosine-related LncRNAs signature for predicting the prognosis of Hepatocellular carcinoma
Y Luo, X Zhang, H Yang - 2022 - researchsquare.com
Background. Hepatocellular carcinoma (HCC) is a highly heterogeneous disease with poor
prognosis, making the prediction of the prognosis much challenges. N7-methylguanosine …
prognosis, making the prediction of the prognosis much challenges. N7-methylguanosine …
Predicting prognosis and immune responses in hepatocellular carcinoma based on N7-methylguanosine-related long noncoding RNAs
Y Dai, Y Gao, L Chen, J Liu, C Zeng, J Zhou… - Frontiers in …, 2022 - frontiersin.org
Background: Hepatocellular carcinoma (HCC), which has high rates of recurrence and
metastasis and is the main reason and the most common tumor for cancer mortality …
metastasis and is the main reason and the most common tumor for cancer mortality …
A new prediction model of hepatocellular carcinoma based on N7-methylguanosine modification
L Yang, Y Wang, Z Mou, P Xiong, K Deng, J Wen… - BMC …, 2023 - Springer
Purpose Hepatocellular carcinoma (HCC) is a kind of primary liver cancer. It is a common
malignant tumor of digestive system that is difficult to predict the prognosis of patients. As an …
malignant tumor of digestive system that is difficult to predict the prognosis of patients. As an …
Comprehensive analysis of nine m7G-related lncRNAs as prognosis factors in tumor immune microenvironment of hepatocellular carcinoma and experimental …
T Wang, Z Zhou, X Wang, L You, W Li, C Zheng… - Frontiers in …, 2022 - frontiersin.org
Background: Hepatocellular carcinoma (HCC) remains the most prevalent gastrointestinal
malignancy worldwide, with robust drug resistance to therapy. N7-methylguanosine (m7G) …
malignancy worldwide, with robust drug resistance to therapy. N7-methylguanosine (m7G) …
Identification of a Novel N7-Methylguanosine-Related LncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma and Experiment Verification
C Yang, L Zhang, X Hao, M Tang, B Zhou, J Hou - Current Oncology, 2022 - mdpi.com
(1) Background: It is well-known that long non-coding RNAs (lncRNAs) and N7-
methylguanosine (m7G) contribute to hepatocellular carcinoma (HCC) progression …
methylguanosine (m7G) contribute to hepatocellular carcinoma (HCC) progression …
Identification and validation of a m7G-related lncRNA signature for predicting the prognosis and therapy response in hepatocellular carcinoma
YL Peng, YF Dong, LL Guo, MY Li, H Liao, RS Li - Plos one, 2023 - journals.plos.org
Background N7-methylguanosine (m7G) is one of the most common RNA posttranscriptional
modifications; however, its potential role in hepatocellular carcinoma (HCC) remains …
modifications; however, its potential role in hepatocellular carcinoma (HCC) remains …
Prognostic signature and tumor immune landscape of N7-methylguanosine-related lncRNAs in hepatocellular carcinoma
W Wei, C Liu, M Wang, W Jiang, C Wang… - Frontiers in …, 2022 - frontiersin.org
Despite great advances in the treatment of liver hepatocellular carcinoma (LIHC), such as
immunotherapy, the prognosis remains extremely poor, and there is an urgent need to …
immunotherapy, the prognosis remains extremely poor, and there is an urgent need to …
Analysis of m6A-related lncRNAs for prognosis value and response to immune checkpoint inhibitors therapy in hepatocellular carcinoma
Y Wang, N Li, D Tian, CW Zhou, YH Wang… - Cancer management …, 2021 - Taylor & Francis
Introduction N6-methyladenosine (m6A) modification and long non-coding RNAs (lncRNAs)
play pivotal roles in the progression of hepatocellular carcinoma (HCC). However, how their …
play pivotal roles in the progression of hepatocellular carcinoma (HCC). However, how their …
[HTML][HTML] Constructing and validating of m7G-related genes prognostic signature for hepatocellular carcinoma and immune infiltration: potential biomarkers for …
P Liu, C Dong, H Shi, Z Yan, J Zhang… - Journal of …, 2022 - ncbi.nlm.nih.gov
Background To investigate the prognostic significance of N7-methylguanosine (m7G)
regulators and immune infiltration in liver hepatocellular carcinoma (LIHC). Methods The …
regulators and immune infiltration in liver hepatocellular carcinoma (LIHC). Methods The …
相关搜索
- n7 methylguanosine hepatocellular carcinoma
- lncrna signature hepatocellular carcinoma
- n7 methylguanosine risk stratification
- risk stratification hepatocellular carcinoma
- n7 methylguanosine lncrnas signature
- identification and validation hepatocellular carcinoma
- prognosis value hepatocellular carcinoma
- immune landscape hepatocellular carcinoma
- n7 methylguanosine immune landscape
- overall survival hepatocellular carcinoma
- comprehensive analysis hepatocellular carcinoma
- n7 methylguanosine experiment verification
- lncrna signature identification and validation
- experiment verification hepatocellular carcinoma
- therapy response hepatocellular carcinoma
- prognostic signature hepatocellular carcinoma